Morgan Stanley
GNCA

Morgan Stanley’s Genocea Biosciences, Inc. GNCA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-28,163
Closed -$35K 8331
2022
Q1
$35K Buy
28,163
+14,527
+107% +$18.1K ﹤0.01% 6880
2021
Q4
$15K Sell
13,636
-2,033
-13% -$2.24K ﹤0.01% 7335
2021
Q3
$30K Sell
15,669
-835
-5% -$1.6K ﹤0.01% 6937
2021
Q2
$39K Buy
16,504
+10,957
+198% +$25.9K ﹤0.01% 6777
2021
Q1
$15K Buy
5,547
+2,139
+63% +$5.78K ﹤0.01% 6830
2020
Q4
$8K Buy
3,408
+1,300
+62% +$3.05K ﹤0.01% 6706
2020
Q3
$5K Sell
2,108
-2,534
-55% -$6.01K ﹤0.01% 6462
2020
Q2
$10K Buy
4,642
+1,769
+62% +$3.81K ﹤0.01% 6174
2020
Q1
$5K Buy
2,873
+464
+19% +$808 ﹤0.01% 6249
2019
Q4
$5K Buy
2,409
+2,407
+120,350% +$5K ﹤0.01% 6411
2019
Q3
$0 Sell
2
-6,612
-100% ﹤0.01% 6957
2019
Q2
$26K Buy
+6,614
New +$26K ﹤0.01% 5850
2019
Q1
Sell
-164
Closed 6827
2018
Q4
$0 Sell
164
-11
-6% ﹤0.01% 6855
2018
Q3
$0 Sell
175
-300,174
-100% ﹤0.01% 6913
2018
Q2
$257K Buy
300,349
+118,101
+65% +$101K ﹤0.01% 5447
2018
Q1
$191K Buy
182,248
+123,405
+210% +$129K ﹤0.01% 5490
2017
Q4
$68K Buy
58,843
+12,130
+26% +$14K ﹤0.01% 5748
2017
Q3
$68K Buy
46,713
+6,242
+15% +$9.08K ﹤0.01% 5689
2017
Q2
$211K Buy
40,471
+24,121
+148% +$126K ﹤0.01% 5302
2017
Q1
$99K Buy
16,350
+7,631
+88% +$46.2K ﹤0.01% 5604
2016
Q4
$36K Sell
8,719
-7,854
-47% -$32.4K ﹤0.01% 5840
2016
Q3
$85K Sell
16,573
-6,299
-28% -$32.3K ﹤0.01% 5381
2016
Q2
$94K Sell
22,872
-3,613
-14% -$14.9K ﹤0.01% 5266
2016
Q1
$205K Sell
26,485
-1,947
-7% -$15K ﹤0.01% 4961
2015
Q4
$150K Sell
28,432
-181,843
-86% -$959K ﹤0.01% 5220
2015
Q3
$1.44M Buy
210,275
+147,719
+236% +$1.01M ﹤0.01% 3803
2015
Q2
$859K Buy
62,556
+31,002
+98% +$426K ﹤0.01% 4323
2015
Q1
$375K Buy
31,554
+30,558
+3,068% +$363K ﹤0.01% 4835
2014
Q4
$7K Sell
996
-1,977
-66% -$13.8K ﹤0.01% 6280
2014
Q3
$27K Sell
2,973
-734
-20% -$6.61K ﹤0.01% 5918
2014
Q2
$70K Sell
3,707
-9,557
-72% -$181K ﹤0.01% 5643
2014
Q1
$240K Buy
+13,264
New +$240K ﹤0.01% 5028